home / stock / mbrx / mbrx news

MBRX News and Press, Moleculin Biotech Inc. From 04/29/20

Stock Information
Company Name: Moleculin Biotech Inc.
Stock Symbol: MBRX
Market: NASDAQ
Website: moleculin.com
Menu
MBRX MBRX Quote MBRX Short MBRX News MBRX Articles MBRX Message Board
Get MBRX Alerts

News, Short Squeeze, Breakout and More Instantly...
MBRX - WPD Pharmaceutical's Annamycin Drug Approved for Accelerated European Clinical Trial

VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the “Company” or “WPD” ) a clinical stage pharmaceutical company is pleased to announce that through its license partner, Moleculin Biotech, Inc...
MBRX - Moleculin Approved to Accelerate European Clinical Trial

HOUSTON , April 28, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that it is now authorized by the Polish Department of Registration of Me...

MBRX - WPD Pharmaceuticals' Annamycin Drug Candidate Meets Endpoint in Successful U.S. Phase 1 AML Trial With No Evidence of Cardiotoxicity

VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the “Company” or “WPD” ) a clinical stage pharmaceutical company is pleased to provide an update on its Annamycin drug candidate. Through its li...

MBRX - Moleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team

HOUSTON , April 22, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that it has welcomed Dr. Richard Whitley to its Science Advisory Board to g...
MBRX - WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company along with its development partner CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (ȁ...

MBRX - Moleculin Bio up 6% premarket on WP1122 deal for COVID-19

Moleculin Biotech (NASDAQ: MBRX ) has entered into an agreement with ImQuest Biosciences to expand in vitro and in vivo testing of WP1122 for the treatment of COVID-19. More news on: Moleculin Biotech, Inc., Healthcare stocks news, Read more ...

MBRX - Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing

HOUSTON , April 20, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates, today announced that it has entered into an agreement with ImQuest Biosciences to expand...
MBRX - AMC, TRNX, RDHL and MBRX among midday movers

Gainers:  Taronis Technologies (NASDAQ: TRNX ) +87% . More news on: Taronis Technologies, Inc., Golden Bull Limited, Genetic Technologies Limited, Stocks on the move, , Read more ...

MBRX - APT, PTON among premarket losers

Pulmatrix (NASDAQ: PULM )  -27%  on $8M direct offering . More news on: Pulmatrix, Inc., Moleculin Biotech, Inc., Cutera, Inc., Stocks on the move, , Read more ...

MBRX - INO, BBBY among premarket gainers

Edison Nation (NASDAQ: EDNT ) +169%  on over  $10M order . More news on: Edison Nation, Inc., Soligenix, Inc., Atossa Therapeutics, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10